Abstract: Startup Vivid Vision announced a partnership with the State University of New York to try to treat amblyopia with VR
Vivid Vision is a US startup that uses VR technology to treat visual impairment. Its founder and executive director, James Blaha, is a low vision patient who has difficulty reading text or watching 3D content. Today, the company announced a partnership with the State University of New York to promote greater progress in the treatment of eye diseases such as amblyopia and strabismus.
Specifically, the company has signed an exclusive licensing agreement with the University's Research Foundation, which allows the company to use the patented system invented by Benjamin Backus, an associate professor at the State University of New York's School of Optometry, and also serves as the chief scientific officer at Vivid Vision. Using eye tracking technology (VR enthusiasts should be aware that this is very important for the future development of the VR platform), can stimulate binocular vision in both eyes of the retina and guide neuron work.
Vivid Vision CEO James Blaha said in a statement: "We believe that eye tracking technology is essential for the treatment of binocular dysfunction, such as amblyopia, strabismus and convergence."
In the next few years, eye tracking technology will play a vital role in the VR industry. On the surface, this technology has new features such as real eye movement and centered rendering. But it will also introduce other new features, such as this type of eye training.
Ningbo Autrends International Trade Co.,Ltd. , https://www.vapee-cigarettes.com